EBV DNA

Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay

Y. Li, Wang, K., .K.Yin, S., Zheng, H. L., Min, D. L., Li, Y., Wang, K., .K.Yin, S., Zheng, H. L., Min, D. L., Li, Y., Wang, K., .K.Yin, S., Zheng, H. L., and Min, D. L., Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay, vol. 15, p. -, 2016.

Epstein-Barr virus (EBV) infection is closely associated with nasopharyngeal carcinoma, which can be monitored by the levels of Rta protein antibody IgG (Rta-IgG), early antigen antibody (EA-IgG), and viral capsid antibody (VCA-IgA). In the present study, we investigated the serum levels of Rta-IgG, EA-IgG, and VCA-IgA in nasopharyngeal cancer patients, and the diagnostic value of a combined assay that includes these antibodies in addition to the EBV-DNA.

Subscribe to EBV DNA